相关实验视频

Updated: Mar 9, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

尼皮拉姆通过PARP1促进乳腺癌的进展:集成多omics分析与实验验证验证

Dongliang Yin¹, Haoyu Qin², Menglan Yan³

¹Affiliated Rehabilitation Hospital of Nanchang University, Nanchang, Jiangxi, China.

Ecotoxicology and environmental safety

|March 7, 2026

概括

尼皮拉姆 (NIT) 是一种常见的跳治疗方法,它通过破坏免疫细胞和遗传稳定性来促进癌症. 高剂量的NIT显著增加了与PARP1表达相关的乳腺癌细胞增殖.

科学领域:

毒理学毒理学毒理学
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

尼皮拉姆 (NIT) 广泛用于物跳控制.
之前的研究表明,NIT暴露与癌症之间存在潜在联系,但潜在的机制尚不清楚.

研究的目的:

使用多平台生物信息学和实验方法研究尼皮拉姆 (NIT) 的致癌机制.
为了确定关键的分子标和涉及到NIT诱导的致癌的途径.

主要方法:

综合生物信息学分析,包括蛋白质-蛋白质相互作用 (PPI) 网络构建和基因丰富分析.
分子对接用于预测NIT和瘤原蛋白之间的相互作用.
单细胞转录组分析以确定免疫细胞中的基因表达.
细胞测试 (蛋白质定量,殖民地形成) 以验证乳腺癌模型中的发现.

主要成果:

确定了26个与NIT暴露相关的核心基因,并绘制了它们的跨癌症表达特征.
分子对接揭示了NIT与KRAS,PARP1,KIT,ITGB1,EGFR和CXCR4的潜在相互作用.
这些基因主要表达在免疫细胞 (T细胞,B细胞) 中.
暴露于NIT促进了乳腺癌细胞的增殖和增加了PARP1的表达,更高的剂量显示出更明显的效果.

结论:

尼皮拉姆 (NIT) 可能通过破坏遗传稳定性和免疫平衡来促进癌症的发展.
尼特直接与参与细胞信号传递和增殖的关键蛋白质相互作用.
实验证据证实,NIT促进了乳腺癌细胞的增殖,突出了PARP1作为潜在的调解者.

关键词:

机器学习机器学习分子动力学模拟模型分子对接是分子对接.尼皮拉姆是什么意思泛癌分析泛癌分析瘤微环境是一个微环境.

更多相关视频

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...